Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Adipose tissue can be divided into white adipose tissue (WAT), brown adipose tissue (BAT), and beige adipose tissue, according to the differences in morphology. WAT acts as a buffer for increased energy intake and decreased energy expenditure during the development of obesity, resulting in visceral and ectopic WAT accumulation. These WAT depots are strongly associated with chronic systemic inflammation, insulin resistance, and cardiometabolic risk related to obesity. They represent a primary weight loss target in anti-obesity management. Second-generation anti-obesity medications glucagon-like peptide-1 receptor agonists (GLP-1RAs) cause weight loss and improve body composition by reducing visceral and ectopic fat depots of WAT, resulting in improved cardiometabolic health. Recently, the understanding of the physiological significance of BAT beyond its primary function in generating heat through non-shivering thermogenesis has been expanded. This has raised scientific and pharmaceutical interest in the manipulation of BAT to further enhance weight reduction and body weight maintenance. This narrative review focuses on the potential impact of GLP-1 receptor agonism on BAT, particularly in human clinical studies. It provides an overview of the role of BAT in weight management and highlights the need for further research to elucidate the mechanisms by which GLP-1RAs affect energy metabolism and weight loss. Despite encouraging preclinical data, limited clinical evidence supports the notion that GLP-1RAs contribute to BAT activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Therefore, BAT activation could potentially improve specific metabolic parameters (hyperglycemia, dyslipidemia) in addition to increasing energy expenditure, making it a viable therapeutic target for obesity and other metabolic diseases [95].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [95]
In the citing paper
“Preclinical research showed that the main mechanism by which GLP-1 causes weight loss is not only by decreasing appetite and hunger but also by increasing energy expenditure, most likely by means of BAT thermogenesis [95].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838 · cited 1×
“However, it has been shown that tirzepatide once weekly is effective in providing a substantial and sustained reduction in body weight in obese persons without diabetes [66].”
BackgroundHaslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · cited 2×
“Initial studies exploring BAT activity demonstrated that BAT is present in both lean and obe e individuals; however, BAT activity was observed to be reduc d in overw ight or obese men [33,34].”
BackgroundDi Angelantonio, E., Bhupathiraju, S. N., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A. B., Cairns, B. J., Huxley, R., Jackson, C. L., Joshy, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30175-1 · Cited by 2,821
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647 · cited 2×
“Since then, several other GLP-1RAs have been approved for type 2 diabetes management, available either for subcutaneous injection (exenatide, lixisenatide, liraglutide, dulaglutide, albiglutide, semaglutide), oral administration (semaglutide), or as fixed-dose combinations (liraglutide/insulin degludec, lixisenatide/i…”
BackgroundAdipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575 · cited 1×
“Fat accumulation in ectopic tissues and the visceral adipose depots has been linked to the unfavorable metabolic profile, inflammation, and insulin resistance and is now positioned as a primary target of adipose tissue reduction [13,14].”
BackgroundChait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529 · cited 4×
“Adipose tissue can be divided into white adipose tissue (WAT), BAT, and beige adipose tissue, according to the morphological differences [23].”
BackgroundInfluentialRubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.1831 · Cited by 1,114 · cited 2×
“4 mg once weekly in adults with overweight or obesity and without diabetes, in addition to intensive behavioral therapy and diet, resulted in significant weight loss, which continued when semaglutide treatment was maintained [19,62].”
BackgroundState of the art paper Biochemistry of adipose tissue: an endocrine organ
Coelho, M., Oliveira, T., & Fernandes, R. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.33181 · Cited by 1,110
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Rubino, D. M., Greenway, F. L., Khalid, U., O’Neil, P. M., Rosenstock, J., Sørrig, R., Wadden, T. A., Wizert, A., Garvey, W. T., STEP 8 Investigators, et al. (2022) · JAMA · doi:10.1001/jama.2021.23619 · Cited by 995 · cited 2×
“Nevertheless, the entire field is keenly anticipating further clinical data on their efficacy and safety [10,18,19].”
BackgroundVilsboll, T., Christensen, M., Junker, A. E., Knop, F. K., & Gluud, L. L. (2012) · BMJ · doi:10.1136/bmj.d7771 · Cited by 970
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
on behalf of the NN8022-1807 Investigators, Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.158 · Cited by 757
Brown Adipose Tissue Improves Whole-Body Glucose Homeostasis and Insulin Sensitivity in Humans
Chondronikola, M., Volpi, E., Børsheim, E., Porter, C., Annamalai, P., Enerbäck, S., Lidell, M. E., Saraf, M. K., Labbe, S. M., Hurren, N. M., et al. (2014) · Diabetes · doi:10.2337/db14-0746 · Cited by 746
Contemporary medical, device, and surgical therapies for obesity in adults
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02403-5 · Cited by 738 · cited 1×
“0 mg/day in weight-loss management [76].”
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Different Metabolic Responses of Human Brown Adipose Tissue to Activation by Cold and Insulin
Orava, J., Nuutila, P., Lidell, M. E., Oikonen, V., Noponen, T., Viljanen, T., Scheinin, M., Taittonen, M., Niemi, T., Enerbäck, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.012 · Cited by 653
Cunningham, J. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.963 · Cited by 607
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., et al. (2014) · Diabetes · doi:10.2337/db14-0302 · Cited by 602 · cited 14×
“Furthermore, exenatide use did not affect the REE (nor when corrected for lean body mass) in the total cohort.”
BackgroundResultInfluentialShort-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
Hanssen, M. J. W., Hoeks, J., Brans, B., van der Lans, A. A. J. J., Schaart, G., van den Driessche, J. J., Jörgensen, J. A., Boekschoten, M. V., Hesselink, M. K. C., Havekes, B., et al. (2015) · Nature Medicine · doi:10.1038/nm.3891 · Cited by 560
Mapping of human brown adipose tissue in lean and obese young men
Leitner, B. P., Huang, S., Brychta, R. J., Duckworth, C. J., Baskin, A. S., McGehee, S., Tal, I., Dieckmann, W., Gupta, G., Kolodny, G. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705287114 · Cited by 530 · cited 3×
“Accordingly, in addition to increasing energy expenditure, BAT activation could potentially improve certain metabolic parameters (hyperglycemia, dyslipidemia), making BAT activation a potential therapeutic target for obesity and other metabolic diseases [16,28].”
BackgroundHany, T. F., Gharehpapagh, E., Kamel, E. M., Buck, A., Himms-Hagen, J., & von Schulthess, G. K. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0902-6 · Cited by 511 · cited 1×
“However, due to advances in medical imaging techniques, namely, fluorine-18 fluorodeoxyglucose positron emission tomography coupled with CT (18F-FDG-PET/CT), BAT was also observed in adults [16,27].”
BackgroundGLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510 · cited 1×
“GLP-1RAs enhance glucose-dependent insulin release, reduce gastric emptying, and decrease glucagon secretion, making them effective drugs in type 2 diabetes management [57].”
BackgroundGLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463 · cited 2×
“Glucagon-like peptide 1 (GLP-1) is a peptide hormone primarily secreted by endocrine cells in the distal intestine, alpha cells in the pancreas, and cells in the central nervous system [55].”
BackgroundRosenbaum, M., Hirsch, J., Gallagher, D. A., & Leibel, R. L. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.906 · Cited by 444 · cited 1×
“This discrepancy could possibly be explained by the fact that the initial studies used different methodologies and treatment periods; however, there is support for the notion that REE decreases after weight loss [80].”
ResultChen, K. Y., Cypess, A. M., Laughlin, M. R., Haft, C. R., Hu, H. H., Bredella, M. A., Enerbäck, S., Kinahan, P. E., Lichtenbelt, W. V. M., Lin, F. I., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.014 · Cited by 308
Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans
Matsushita, M., Yoneshiro, T., Aita, S., Kameya, T., Sugie, H., & Saito, M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.206 · Cited by 299
Ard, J., Fitch, A., Fruh, S., & Herman, L. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01710-0 · Cited by 297 · cited 1×
“GLP1-RAs-induced weight loss can be attributed to several proposed mechanisms of action, including reductions in appetite and hunger, alterations in food reward pathways, and improvement in eating control [63].”
BackgroundOrava, J., Nuutila, P., Noponen, T., Parkkola, R., Viljanen, T., Enerbäck, S., Rissanen, A., Pietiläinen, K. H., & Virtanen, K. A. (2013) · Obesity · doi:10.1002/oby.20456 · Cited by 257
Heterogeneity of white adipose tissue: molecular basis and clinical implications
Kwok, K. H. M., Lam, K. S. L., & Xu, A. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.5 · Cited by 252
White adipose tissue mitochondrial metabolism in health and in obesity
Heinonen, S., Jokinen, R., Rissanen, A., & Pietiläinen, K. H. (2020) · Obesity Reviews · doi:10.1111/obr.12958 · Cited by 240
Lockie, S. H., Heppner, K. M., Chaudhary, N., Chabenne, J. R., Morgan, D. A., Veyrat-Durebex, C., Ananthakrishnan, G., Rohner-Jeanrenaud, F., Drucker, D. J., DiMarchi, R., et al. (2012) · Diabetes · doi:10.2337/db11-1556 · Cited by 237
Brown Adipose Tissue: an Update on Recent Findings
Marlatt, K. L., & Ravussin, E. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0283-6 · Cited by 229
Willoughby, D., Hewlings, S., & Kalman, D. (2018) · Nutrients · doi:10.3390/nu10121876 · Cited by 221 · cited 1×
“With the increased focus on adipose tissue, the efficacy of various weight loss interventions on body composition and adipose tissue distribution has gained an essential role in the determination of weight loss success [12].”
BackgroundInduction of Adipose Tissue Browning as a Strategy to Combat Obesity
Kuryłowicz, A., & Puzianowska-Kuźnicka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176241 · Cited by 219
Increase in Brown Adipose Tissue Activity after Weight Loss in Morbidly Obese Subjects
Vijgen, G. H. E. J., Bouvy, N. D., Teule, G. J. J., Brans, B., Hoeks, J., Schrauwen, P., & van Marken Lichtenbelt, W. D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1289 · Cited by 212
Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review
Chavda, V. P., Ajabiya, J., Teli, D., Bojarska, J., & Apostolopoulos, V. (2022) · Molecules · doi:10.3390/molecules27134315 · Cited by 208
An overview of GLP-1 agonists and recent cardiovascular outcomes trials
Sheahan, K. H., Wahlberg, E. A., & Gilbert, M. P. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-137186 · Cited by 194 · cited 1×
“The first GLP-1RA approved by the FDA for type 2 diabetes treatment was exenatide in 2005 [58].”
BackgroundBrown Adipose Tissue Development and Metabolism
Jung, S. M., Sánchez-Gurmaches, J., & Guertin, D. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_168 · Cited by 184
Nogueiras, R., Pérez-Tilve, D., Veyrat-Durebex, C., Morgan, D. A., Varela, L., Haynes, W. G., Patterson, J. T., Disse, E., Pfluger, P. T., López, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5977-08.2009 · Cited by 182 · cited 1×
“Importantly, in diet-induced obese mice, the central nervous system GLP-1 effect on adipocyte metabolism was blunted, suggesting possible obesity-induced resistance of adipocytes to the central nervous system GLP-1 [67].”
BackgroundHorowitz, M., Flint, A., Jones, K. L., Hindsberger, C., Rasmussen, M. F., Kapitza, C., Doran, S., Jax, T., Zdravkovic, M., & Chapman, I. M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.016 · Cited by 179 · cited 13×
“Furthermore, exenatide use did not affect the REE (nor when corrected for lean body mass) in the total cohort.”
ResultInfluentialIqbal, J., Wu, H., Hu, N., Zhou, Y., Li, L., Xiao, F., Wang, T., Jiang, H., Xu, S., Huang, B., et al. (2022) · Obesity Reviews · doi:10.1111/obr.13435 · Cited by 179 · cited 1×
“The results of both studies are in line with the well-documented effects of GLP-1RAs on body weight reduction [77,78].”
ResultBrown adipose tissue takes up plasma triglycerides mostly after lipolysis
Khedoe, P. P. S. J., Hoeke, G., Kooijman, S., Dijk, W., Buijs, J. T., Kersten, S., Havekes, L. M., Hiemstra, P. S., Berbée, J. F. P., Boon, M. R., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m052746 · Cited by 169
Crichton, P. G., Lee, Y., & Kunji, E. R. S. (2017) · Biochimie · doi:10.1016/j.biochi.2016.12.016 · Cited by 144
Kooijman, S., Wang, Y., Parlevliet, E. T., Boon, M. R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J. A., & Rensen, P. C. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3727-0 · Cited by 140 · cited 1×
“Most importantly, these effects were accompanied by a reduction in body weight and lower plasma triacylglycerol as well as glucose concentrations [69].”
BackgroundHuman Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
Singh, R., Barrios, A., Dirakvand, G., & Pervin, S. (2021) · Cells · doi:10.3390/cells10113030 · Cited by 125
Advantages and Applications of Total-Body PET Scanning
Katal, S., Eibschutz, L. S., Saboury, B., Gholamrezanezhad, A., & Alavi, A. A. (2022) · Diagnostics · doi:10.3390/diagnostics12020426 · Cited by 114
Cold and Exercise: Therapeutic Tools to Activate Brown Adipose Tissue and Combat Obesity
da Silva, C. P. V., Hernández‐Saavedra, D., White, J. D., & Stanford, K. (2019) · Biology · doi:10.3390/biology8010009 · Cited by 112
New horizons. A new paradigm for treating to target with second-generation obesity medications
Garvey, W. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab848 · Cited by 110
Wibmer, A. G., Becher, T., Eljalby, M., Crane, A., Andrieu, P. C., Jiang, C. S., Vaughan, R., Schöder, H., & Cohen, P. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100332 · Cited by 105
Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity
Jensterle, M., Ferjan, S., Ležaič, L., Sočan, A., Goričar, K., Zaletel, K., & Janez, A. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14944 · Cited by 102
Self-citationNuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments
Samim, A., Tytgat, G. A. M., Bleeker, G., Wenker, S. T. M., Chatalic, K. L. S., Poot, A. J., Tolboom, N., van Noesel, M. M., Lam, M. G. E. H., & de Keizer, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040270 · Cited by 98
Contribution of brown adipose tissue to human energy metabolism
Fernández-Verdejo, R., Marlatt, K. L., Ravussin, E., & Galgani, J. E. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.003 · Cited by 83
Activation and recruitment of brown adipose tissue by cold exposure and food ingredients in humans
Saito, M., Yoneshiro, T., & Matsushita, M. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.08.003 · Cited by 71
Scheel, A. K., Espelage, L., & Chadt, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094759 · Cited by 71
Ruiz, J. R., Martinez-Tellez, B., Sanchez-Delgado, G., Osuna-Prieto, F. J., Rensen, P. C. N., & Boon, M. R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.002 · Cited by 63
McNeill, B. T., Suchacki, K. J., & Stimson, R. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1439 · Cited by 62
Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity
Rachid, B., van de Sande‐Lee, S., Rodovalho, S., Folli, F. B., Beltramini, G. C., Morari, J., Amorim, B. J., Pedro, T., Ramalho, A. F. S., Bombassaro, B., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.94 · Cited by 55
Relevance of lipid metabolism for brown fat visualization and quantification
Schilperoort, M., Hoeke, G., Kooijman, S., & Rensen, P. C. N. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000296 · Cited by 55
van Eyk, H. J., Paiman, E. H. M., Bizino, M. B., IJzermans, S. L., Kleiburg, F., Boers, T. G. W., Rappel, E. J., Burakiewicz, J., Kan, H. E., Smit, J. W. A., et al. (2020) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.005 · Cited by 54
Janssen, L. G. M., Nahon, K. J., Bracké, K. F. M., van den Broek, D., Smit, R., Sardjoe Mishre, A. S. D., Koorneef, L. L., Martinez-Tellez, B., Burakiewicz, J., Kan, H. E., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154167 · Cited by 54
Active Brown Adipose Tissue Is Associated With a Healthier Metabolic Phenotype in Obesity
Herz, C. T., Kulterer, O. C., Prager, M., Schmöltzer, C., Langer, F. B., Prager, G., Marculescu, R., Kautzky-Willer, A., Hacker, M., Haug, A. R., et al. (2022) · Diabetes · doi:10.2337/db21-0475 · Cited by 54
Sun, L., Verma, S. K., Michael, N., Chan, S. P., Yan, J., Sadananthan, S. A., Camps, S. G., Goh, H. J., Govindharajulu, P., Totman, J. J., et al. (2019) · Obesity · doi:10.1002/oby.22560 · Cited by 53
Law, J., Chalmers, J., Morris, D. E., Robinson, L., Budge, H., & Symonds, M. E. (2018) · Temperature · doi:10.1080/23328940.2017.1397085 · Cited by 52
Admiraal, W. M., Holleman, F., Bahler, L., Soeters, M. R., Hoekstra, J. B. L., & Verberne, H. J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111849 · Cited by 50
Huo, C., Song, Z., Yin, J., Zhu, Y., Miao, X., Qian, H., Wang, J., Ye, L., & Zhou, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.917084 · Cited by 49
Overfeeding Over 24 Hours Does Not Activate Brown Adipose Tissue in Humans
Schlögl, M., Piaggi, P., Thiyyagura, P., Reiman, E. M., Chen, K., Lutrin, C., Krakoff, J., & Thearle, M. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2387 · Cited by 47
Gutierrez, A. D., Gao, Z., Hamidi, V., Zhu, L., Saint Andre, K. B., Riggs, K., Ruscheinsky, M., Wang, H., Yu, Y., Miller, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100813 · Cited by 44 · cited 1×
“Thus, the researchers suggested that GLP-1RAs mediate their metabolic effects through transient upregulation of interleukin-6, in turn, activating thermogenesis [72].”
BackgroundMolecular Imaging of Brown Adipose Tissue Mass
Yang, J., Zhang, H., Parhat, K., Xu, H. X., Li, M., Wang, X., & Ran, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179436 · Cited by 42
Stahl, V., Maier, F., Freitag, M. T., Floca, R. O., Berger, M. C., Umathum, R., Berriel Diaz, M., Herzig, S., Weber, M.-A., Dimitrakopoulou-Strauss, A., et al. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25364 · Cited by 41
Loh, R. K. C., Formosa, M. F., Eikelis, N., Bertovic, D. A., Anderson, M. J., Barwood, S. A., Nanayakkara, S., Cohen, N. D., Gerche, A. L., Reutens, A. T., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4479-9 · Cited by 37
Uncoupling Protein 1 Does Not Produce Heat without Activation
Li, Y., & Fromme, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052406 · Cited by 37
Brown Adipose Tissue Prevalence Is Lower in Obesity but Its Metabolic Activity Is Intact
Kulterer, O. C., Herz, C. T., Prager, M., Schmöltzer, C., Langer, F. B., Prager, G., Marculescu, R., Kautzky-Willer, A., Hacker, M., Haug, A. R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.858417 · Cited by 36
Associations Between Mental Health, Quality of Life, and Obesity/Metabolic Risk Phenotypes
Kim, S.-R., Kim, H.-N., & Song, S.-W. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0028 · Cited by 34
Mihalopoulos, N. L., Yap, J. T., Beardmore, B. E., Holubkov, R., Nanjee, M. N., & Hoffman, J. M. (2020) · Obesity · doi:10.1002/oby.22767 · Cited by 30
Oliveira, F. C. B., Bauer, E. J., Ribeiro, C. M., Pereira, S. A., Beserra, B. T. S., Wajner, S. M., Maia, A. L., Neves, F. A. R., Coelho, M. S., & Amato, A. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.803363 · Cited by 30 · cited 1×
“Most importantly, liraglutide increased BAT type 2 deiodinase activity, suggesting that it may activate BAT by increasing intracellular thyroid activation and thus facilitating weight loss [71].”
BackgroundHuman Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic AvenuesPreprint
Singh, R., Barrios, A., Dirakvand, G., et al. (2021) · Preprints.org · doi:10.20944/preprints202110.0005.v1 · Cited by 29
Brown Adipose Tissue: New Challenges for Prevention of Childhood Obesity. A Narrative Review
Verduci, E., Calcaterra, V., Profio, E. D., Fiore, G., Rey, F., Magenes, V. C., Todisco, C. F., Carelli, S., & Zuccotti, G. (2021) · Nutrients · doi:10.3390/nu13051450 · Cited by 22
The role of comorbidity in the association of obesity with unemployment and disability
Strat, Y. L., Melchior, M., Gorwood, P. A. P. M., Tebeka, S., & Dubertret, C. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.03.004 · Cited by 20
Perez, L. C., Perez, L. T., Nene, Y., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037458 · Cited by 17 · cited 2×
“Furthermore, a recent systematic review identified twenty-two human studies of mostly short durations that tested the use of cold exposure [47].”
BackgroundKaineder, K., Birngruber, T., Rauter, G., Obermüller, B., Eichler, J., Münzker, J., Al-Zoughbi, W., Mautner, S., Torekov, S. S., Hartmann, B., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.98 · Cited by 15
Chondronikola, M., & Sarkar, S. (2020) · PET Clinics · doi:10.1016/j.cpet.2020.09.001 · Cited by 13
Crandall, J. P., & Wahl, R. L. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246991 · Cited by 8
Leow, M. K. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.378 · Cited by 5
Cited by
Spotlight on the Mechanism of Action of Semaglutide
Papakonstantinou, I. P., Tsioufis, K. P., & Katsi, V. K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120872 · Cited by 102
Ngene, N. C., & Moodley, J. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102473 · Cited by 71
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity
Volčanšek, Š., Koceva, A., Jensterle, M., Janež, A., & Muzurović, E. M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01733-8 · Cited by 35
Self-citationMuzurović, E. M., Katsiki, N., Volčanšek, Š., Plescia, F., Rizzo, M., & Mantzoros, C. S. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156494 · Cited by 25
Quagliariello, V., Canale, M. L., Bisceglia, I., Iovine, M., Giordano, V., Giacobbe, I., Scherillo, M., Gabrielli, D., Maurea, C., Barbato, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011299 · Cited by 23
Metadata
- Authors
- Hropot, T., Herman, R., Janez, A., Lezaic, L., & Jensterle, M.
- Affiliations
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Department for Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
- Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
- Corresponding author
- Jensterle, Mojca
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-05-11
- Volume
- 24
- Issue
- 10
- Pages
- 8592
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10218520
- OpenAlex
- W4378515206
- Cited by
- 39
- References
- 94
- Citations by year
- 2026: 15 · 2025: 12 · 2024: 11 · 2023: 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Slovenian Research Agency (ARRS) (P3-0298)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- brown adipose tissue, GLP-1 receptor agonists, obesity treatment, weight loss, beige adipose tissue, white adipose tissue, non-shivering thermogenesis, energy metabolism, insulin resistance, cardiometabolic risk, visceral fat, anti-obesity drugs
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Adipose Tissue, Brown, Cardiovascular Diseases, Energy Metabolism, Humans, Obesity, Weight Loss, Thermogenesis, Glucagon-Like Peptide 1, Adipose Tissue, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.